e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
COPD - diagnosis and staging II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluating acute bronchodilator response with subjective and objective criteria in stable COPD patients
T. Kiratli Karakaya, B. A. Dursun, N. Ucar, S. Alpar, B. Kurt (Ankara, Turkey)
Source:
Annual Congress 2005 - COPD - diagnosis and staging II
Session:
COPD - diagnosis and staging II
Session type:
Thematic Poster Session
Number:
511
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Kiratli Karakaya, B. A. Dursun, N. Ucar, S. Alpar, B. Kurt (Ankara, Turkey). Evaluating acute bronchodilator response with subjective and objective criteria in stable COPD patients. Eur Respir J 2005; 26: Suppl. 49, 511
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Evaluation of the individual bronchodilator response in patients with severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001
Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009
Evaluation of bronchodilator responses in patients with advanced COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001
Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Does acute bronchodilator test is predictive of inhaled corticosteroid response in COPD/asthma patients?
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
The bronchodilator response and clinical characteristics of patients with bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
A realistic study assessing inhaled treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001
Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 267s
Year: 2001
Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Home NIV after an acute exacerbation of COPD: criteria and outcomes
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021
Withdrawal of high-dose inhaled corticosteroids in COPD patients with mild or moderate airflow limitation: a feasibility study in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Sensitivity of the clinical COPD questionnaire to measure disease control in COPD patients referred for pulmonary rehabilitation
Source: Annual Congress 2008 - Respiratory mechanics, muscles and breathing; functional status measures and coping styles
Year: 2008
The impact of using different symptom-based exacerbation definitions in COPD patients
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults
Source: ERJ Open Res, 7 (4) 00293-2021; 10.1183/23120541.00293-2021
Year: 2021
Immediate bronchodilator response in FEV
1
as a diagnostic criterion for adult asthma
Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept